KORU Medical Systems, Inc.
$4.00
The Read: KRMD’s stock showed little reaction to strong Q4 2025 revenue growth and EU MDR certification amid CEO uncertainty, then rallied about 11% after Q1 2026 revenue beat reassured investors on new leadership and gained 7% on positive clinical data for its FreedomEDGE system.
Price
Overlays
Panel
KRMD
Hover to view data
No Data